|

Chemotherapy Regimen 2 Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Pfizer2

Indications

  • Carcinoma, Non-Small-Cell Lung (NSCLC)2
  • Lung Cancer2
  • Non Small Cell Lung Cancer2
  • Cancer2
  • Non-Small Cell Lung Cancer Non-squamous1

Bullhead City, Arizona1 trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pioneer Research Center

Phase 3

Hinsdale, Illinois1 trial

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Hope and Healing Clinical Research

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.